The Journal of Pediatrics
Volume 155, Issue 2 , Pages 266-270 , August 2009

Detection of Multiple Superantigen Genes in Stools of Patients with Kawasaki Disease

Received 13 November 2008 ,Revised 21 January 2009 ,Accepted 6 March 2009.

References 

  1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of fingers and toes in children: clinical observation of 50 cases. Jpn J Allergol. 1967;16:178–222
  2. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med. 1995;149:779–783
  3. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 2008;40:35–42
  4. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A. 1992;89:4066–4070
  5. Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993;342:1385–1388
  6. Curtis N, Zheng R, Lamb JR, Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child. 1995;72:308–311
  7. Yoshioka T, Matsutani T, Toyosaki-Maeda T, Suzuki H, Uemura S, Suzuki R, et al. Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease. Pediatr Res. 2003;53:403–410
  8. Reichardt P, Lehmann I, Sierig G, Borte M. Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease. Infection. 2002;30:360–364
  9. Yamashiro Y, Nagata S, Oguchi S, Shimizu T. Selective increase of V beta 2 + T cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res. 1996;39:264–266
  10. Brogan PA, Shah V, Clarke LA, Dillon MJ, Klein N. T cell activation profiles in Kawasaki syndrome. Clin Exp Immunol. 2008;151:267–274
  11. Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr. 2002;140:742–746
  12. Nomura Y, Masuda K, Yoshinaga M, Takei S, Miyata K. Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age. Pediatr Infect Dis J. 2003;22:794–798
  13. Matsubara K, Fukaya T, Miwa K, Shibayama N, Nigami H, Harigaya H, et al. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease. Clin Exp Immunol. 2006;143:427–434
  14. Japanese Kawasaki disease Research Committee. Diagnostic Guidelines of Kawasaki Disease. 5th ed.. Tokyo: Japanese Kawasaki Disease Research Committee; 2002;
  15. Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol. 2003;133:299–306
  16. Rowley AH. The etiology of Kawasaki disease: superantigen or conventional antigen?. Pediatr Infect Dis J. 1999;18:69–70
  17. Booka M, Okuda M, Shin K, Miyashiro E, Hayashi H, Yamauchi K, et al. Polymerase chain reaction–restriction length polymorphism analysis of clarithromycin-resistant Helicobacter pylori infection in children using stool sample. Helicobacter. 2005;10:205–213
  18. Tahara M, Baba K, Waki K, Arakaki Y. Analysis of Kawasaki disease showing elevated antibody titers of Yersinia pseudotuberculosis. Acta Paediatr. 2006;95:1661–1664
  19. Leen C, Ling S. Mycoplasma infection and Kawasaki disease. Arch Dis Child. 1996;75:266–267
  20. Kikuta H, Matsumoto S, Osato T. Kawasaki disease and Epstein-Barr virus. Acta Paediatr Jpn. 1991;33:765–770
  21. Nakamura Y, Hirose K, Yanagawa H, Kato H, Kawasaki T. Incidence rate of recurrent Kawasaki disease in Japan. Acta Paediatr. 1994;83:1061–1064
  22. Vojtek I, Pirzada ZA, Henriques-Normark B, Mastny M, Janapatla RP, Charpentier E. Lysogenic transfer of group A Streptococcus superantigen gene among Streptococci. J Infect Dis. 2008;197:225–234
  23. Horita N, Yokota S, Fuse S, Takamuro M, Tomita H, Sato K, et al. The throat flora and its mitogenic activity in patients with Kawasaki disease. Microbiol Immunol. 2004;48:899–903
  24. Rajagopalan G, Polich G, Sen MM, Singh M, Epstein BE, Lytle AK, et al. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice. Tissue Antigens. 2008;71:135–145
  25. Norrby-Tegkund A, Nepom GT, Kotb M. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles. Eur J Immunol. 2002;32:2570–2577
  26. Llewelyn M, Sriskandan S, Peakman M, Ambrozak DR, Douek DC, Kwok WW, et al. HLA class II polymorphism determine responses to bacterial superantigens. J Immunol. 2004;172:1719–1726
  27. Nooh MM, El-Gengehi N, Kansal R, David CS, Kotb M. HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of Streptococcal sepsis. J Immunolo. 2007;178:3076–3083

 Supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2006-2008) and a grant from Japan Kawasaki Disease Research Center (2007).

 Presented in part at the Ninth International Kawasaki Disease Symposium, Taipei, Taiwan (April 2008).

PII: S0022-3476(09)00233-9

doi: 10.1016/j.jpeds.2009.03.013

The Journal of Pediatrics
Volume 155, Issue 2 , Pages 266-270 , August 2009

Article Tools

* Image Usage & Resolution